ARTICLE SUMMARY:
Saranas has developed the first FDA-approved internal bleed monitor with the potential to minimize the impact of bleeding complications during and after endovascular interventions. The Early Bird system uses bioimpedance to detect blood loss and alerts healthcare staff so they can make informed decisions on the next steps for patients.
A 2017 study indicates that bleeding complications occur in 18% of large-bore catheter-based procedures. When bleeding events occur, they increase mortality rates threefold and incur an average of $18,000 in incremental costs. Internal bleeding is nearly impossible to notice until it is too late as blood can hemorrhage into any body cavity to a potentially fatal extent.
